Neil O'Neill Gilmore, CEO at Editas Medicine, Inc. (EDIT), sold 1,555 shares at $3.42 ($5K) on 2024-09-04, disclosed to the SEC on 2024-09-06.
Open-market sale of $5k EDIT by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EDIT | SELL | 2026-03-04 | $11K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $12K | — | Filing → |
| EDIT | SELL | 2025-09-04 | $15K | — | Filing → |